303 related articles for article (PubMed ID: 24026158)
1. Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature.
Singh K; Ahmadinia K; Park DK; Nandyala SV; Marquez-Lara A; Patel AA; Fineberg SJ
Spine (Phila Pa 1976); 2014 Jan; 39(1):91-101. PubMed ID: 24026158
[TBL] [Abstract][Full Text] [Related]
2. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
3. Complications related to osteobiologics use in spine surgery: a systematic review.
Mroz TE; Wang JC; Hashimoto R; Norvell DC
Spine (Phila Pa 1976); 2010 Apr; 35(9 Suppl):S86-104. PubMed ID: 20407355
[TBL] [Abstract][Full Text] [Related]
4. Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine.
Chrastil J; Low JB; Whang PG; Patel AA
Spine (Phila Pa 1976); 2013 Jul; 38(16):E1020-7. PubMed ID: 23629484
[TBL] [Abstract][Full Text] [Related]
5. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein.
Fineberg SJ; Ahmadinia K; Oglesby M; Patel AA; Singh K
Spine (Phila Pa 1976); 2013 Jul; 38(15):1304-9. PubMed ID: 23462577
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
[TBL] [Abstract][Full Text] [Related]
8. Off-label use of bone morphogenetic proteins in the United States using administrative data.
Ong KL; Villarraga ML; Lau E; Carreon LY; Kurtz SM; Glassman SD
Spine (Phila Pa 1976); 2010 Sep; 35(19):1794-800. PubMed ID: 20700081
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.
Cahill KS; Chi JH; Day A; Claus EB
JAMA; 2009 Jul; 302(1):58-66. PubMed ID: 19567440
[TBL] [Abstract][Full Text] [Related]
10. Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.
Williams BJ; Smith JS; Fu KM; Hamilton DK; Polly DW; Ames CP; Berven SH; Perra JH; Knapp DR; McCarthy RE; Shaffrey CI;
Spine (Phila Pa 1976); 2011 Sep; 36(20):1685-91. PubMed ID: 21897187
[TBL] [Abstract][Full Text] [Related]
11. The minimally effective dose of bone morphogenetic protein in posterior lumbar interbody fusion: a systematic review and meta-analysis.
Lytle EJ; Lawless MH; Paik G; Tong D; Soo TM
Spine J; 2020 Aug; 20(8):1286-1304. PubMed ID: 32339767
[TBL] [Abstract][Full Text] [Related]
12. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
[TBL] [Abstract][Full Text] [Related]
13. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).
Wong DA; Kumar A; Jatana S; Ghiselli G; Wong K
Spine J; 2008; 8(6):1011-8. PubMed ID: 18037352
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review.
Mindea SA; Shih P; Song JK
Spine (Phila Pa 1976); 2009 Jun; 34(14):1480-4; discussion 1485. PubMed ID: 19525840
[TBL] [Abstract][Full Text] [Related]
15. Anterior lumbar spine surgery: a systematic review and meta-analysis of associated complications.
Bateman DK; Millhouse PW; Shahi N; Kadam AB; Maltenfort MG; Koerner JD; Vaccaro AR
Spine J; 2015 May; 15(5):1118-32. PubMed ID: 25728552
[TBL] [Abstract][Full Text] [Related]
16. Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.
Goode AP; Richardson WJ; Schectman RM; Carey TS
Spine J; 2014 Sep; 14(9):2051-9. PubMed ID: 24321129
[TBL] [Abstract][Full Text] [Related]
17. The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database.
Veeravagu A; Cole TS; Jiang B; Ratliff JK; Gidwani RA
Spine J; 2014 Dec; 14(12):2929-37. PubMed ID: 24842396
[TBL] [Abstract][Full Text] [Related]
18. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
19. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment.
De Stefano FA; Elarjani T; Burks JD; Burks SS; Levi AD
World Neurosurg; 2021 Dec; 156():e64-e71. PubMed ID: 34530148
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Lumbar Fusion Rates With and Without the Use of rhBMP-2.
Galimberti F; Lubelski D; Healy AT; Wang T; Abdullah KG; Nowacki AS; Benzel EC; Mroz TE
Spine (Phila Pa 1976); 2015 Jul; 40(14):1132-9. PubMed ID: 25955186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
